Clinical trial
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 10, 2025
- Completion date
- March 19, 2026
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinitis, nasal obstruction